Drug Trial Radar · NCT02428062
Target Hemodynamics and Brain Injury During General Anesthesia in the Elderly
Last checked: Nov 19, 2026Latest source record: Apr 13, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
1,812
Planned (sponsor's estimate)
Start
Oct 2014
Primary completion
Dec 2018
Study completion Dec 2019
Sponsor
- Lead sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 28, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
BACKGROUND: Post-operative cognitive dysfunction (POCD) is a potentially irreversible loss of brain functions observed in elderly patients after surgical operations under general anaesthesia. POCD at 3 post-operative months is observed in up to 15% of patients aged 70 years and more, and the only recognized risk factor for this condition is increasing age. Importantly, the incidence of POCD at 3 months has been associated to an increased disability and mortality. OBJECTIVES: The present study will evaluate in patients aged 75 years and older undergoing general anaesthesia for non-cardiac surgery, whether an hemodynamic strategy, aiming at maintaining intra-operative arterial blood pressure close to patient's preoperative blood pressure, i.e., to avoid hypotensive episodes, reduces the incidence of POCD at three months. METHODS: Around 1800 consecutive patients scheduled to undergo general anaesthesia for elective non-cardiac surgery will be enrolled. Each patient's cognitive function will be evaluated preoperatively and at 3 months and 1 year postoperatively, together with the occurrence of hearing loss and vestibular function impairment. Furthermore, the incidence of postoperative delirium and cardiovascular, respiratory and infectious complications will be evaluated. EXPECTED RESULTS: The primary outcome is a 25% relative reduction in the incidence of POCD at 3 postoperative months. Secondary outcomes are the reduction of POCD incidence at 1 postoperative year, a reduction in postoperative hearing loss and vestibular impairment at 3 months, a reduction in the incidence of delirium. Hospital length of stay and 90 day mortality will also be assessed. This present study could have a high socio-economic impact, reduce healthcare costs and patient morbidity and mortality with a simple not expensive intraoperative intervention.
Conditions
- Post-operative Cognitive Dysfunction
Interventions
Hemodynamic targetProcedure
The anaesthesiologist is requested to maintain intraoperative mean arterial blood pressure of the patient within 10% of the baseline mean arterial blood pressure (recorded during the preoperative evaluation) of that patient. In order to reach this hemodynamic target the anesthesiologist can choose between one or more of the following four sub-interventions: 1. vasoconstrictor agents (either phenylephrine, ephedrine, epinephrine, norepinephrine or dopamine) 2. intravenous fluids 3. patient's positioning 4. reduction of depth of anesthesia
PhenylephrineDrug
Phenylephrine 0.1-0.2 mg intravenous bolus
Intravenous fluidsDrug
A crystalloid fluid bolus is given intravenously (5-10 ml/kg)
Patient's positioningProcedure
The operating table is positioned so that the patient's head lies below the level of the patient's feet (Trendelenburg position) in order to increase venous return
Reduction of depth of anesthesiaProcedure
The halogenated anesthetic vapor's inspiratory fraction is decreased in order to reduce the associated peripheral vasodilation
EphedrineDrug
Ephedrine 5-25 mg intravenous bolus
EpinephrineDrug
Epinephrine 5-10 mcg intravenous bolus
NorepinephrineDrug
Norepinephrine 0.01 - 0.1 mcg/kg/min intravenous continuous infusion
DopamineDrug
Dopamine 5 - 10 mcg/kg/min intravenous continuous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post-operative cognitive dysfunction (POCD) at 3 monthsTime frame: 3 months after surgical operation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico; Via F. Sforza 35
Milan, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.